This study was undertaken to determine whether p53 or bcl-2 immunoexpression has any significance in the prognosis of laryngeal squamous cell carcinoma. Eighty-four cases of laryngeal squamous cell carcinoma at different pathological stages and locations were studied. All patients were treated surgically first, and followed up for 6 -96 months (mean, 35 months). p53 and bcl-2 immunoexpression in tumour cells, evaluated by image analysis and histoscore, were found in 71.4% and 46.4% of tumours, respectively. Glottic location was correlated with significantly longer survival than tumours at other locations. Pathological stage and histological grade of tumour were also significant predictors of survival. Neither p53 nor bcl-2 immunoexpression was found to be predictive of post-operative survival. Only transglottic tumours expressed significantly high levels of bcl-2. Both methods used to evaluate p53 and bcl-2 immunoexpression correlated well with each other. This study suggests that immunoexpression of p53 and bcl-2 is not a significant prognostic predictor in laryngeal squamous cell carcinoma.
Introduction
Recent advances have been made in the understanding of the pathophysiology and natural history of laryngeal carcinoma, including identification of prognostic and predictive factors. p53 and bcl-2 expression has been correlated with prognosis in certain epithelial tumours, and is frequently altered in laryngeal squamous cell carcinoma. The significance of their overexpression in laryngeal carcinoma is not fully understood, and published studies are not in agreement. 1 -6 It is not clear whether the discrepancy is due to the small numbers of cases examined or the methods applied to validate immunoexpression in these studies. In this study, we used semi-quantitative and quantitative measures to assess the prognostic value of p53 and bcl-2 in laryngeal carcinoma.
Materials and methods
Eighty-four patients aged between 35 and 85 years with primary laryngeal squamous cell carcinoma were included in the study. After undergoing primary surgical therapy, patients were followed up for 6 -96 months (mean, 35 months) to assess outcome.
Sections of each tumour removed at surgery were prepared for routine microscopic evaluation by staining formalin-fixed paraffin-embedded sections with haematoxylin and eosin stain. Additional sections providing a surface area of at least 1 cm 2 were stained immunohistochemically (BioGenex, CA, USA) for p53 and bcl-2. Cytoplasmic immunoexpression of bcl-2 and nuclear immunoexpression of p53 were quantified by a SAMBA image analysis system using Immuno A semi-quantitative method, known as histoscore, was also applied to the immunohistochemically stained sections (Staining percentage of cells × staining density [0, 1, 2, 3, 4] = Histoscore). 7 Quantitative and semi-quantitative values of p53 and bcl-2 protein expression for each tumour were analysed statistically to identify any correlation with tumour localization, pathological stage of the disease, tumour grade or post-operative survival rate. Statistical analysis was performed using SPSS v 9.0 (SPSS, Chicago, IL, USA). Assessments of correlations between survival and tumour localization, disease stage and tumour grade were also made.
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Glottic (n = 53), supraglottic (n = 22), subglottic (n = 6) and transglottic (n = 3) tumours were pT1 in 42 patients, pT2 in 17, pT3 in 13 and pT4 in 12. The survival rate was significantly higher in patients with glottic tumours (34.66 ± 21.73 months) compared with those with tumours in other locations (P < 0.004). Pathological stage and histological grade of tumour were also significant predictors of survival (P < 0.007).
Of the 84 tumour samples, p53 expression was present to various degrees in 60 samples, and was negative in 17. In four of the remaining seven cases, although the histoscore approach detected immunoexpression, the computer-aided quantification strategy performed in per cell mode was not able to detect any immunoexpression. However, in three other cases the opposite was true. Whereas the computer-aided quantification strategy detected immunoexpression, the histoscore approach failed to detect it.
bcl-2 expression was seen to various degrees in 39 of the 84 tumour samples, and was negative in 38 samples. In five of the remaining seven cases, immunoexpression was detected by the histoscore approach but not by the computer-aided quantification strategy, and in two cases positive results were found with the computer-aided quantification strategy, but not with the histoscore approach. The methods used to evaluate p53 and bcl-2 immunoexpression correlated well with each other (r = 0.86). Neither p53 nor bcl-2 expressions were found to have any significant correlation with postoperative survival (P ≥ 0.19).
There was a non-significant trend for correlation between p53 expression level and histological grade. No significant difference in p53 immunoexpression was seen between the four tumour locations (P ≥ 0.21) or tumour stages (P ≥ 0.18).
No significant correlation was found between bcl-2 expression and tumour stage or histological grade (P ≥ 0.12). However, transglottic tumours expressed significantly higher bcl-2 than did tumours in other locations (P = 0.01).
Discussion
The p53 protein plays a role in apoptosis and regulates cell growth and proliferation, inhibiting the cell cycle to allow DNA repair. 8 Abnormalities in this gene are the most frequent genetic alteration identified in laryngeal squamous cell carcinoma, with an abnormal accumulation of the protein correlating with the presence of mutated p53 gene. 9 Uhlman et al. 9 found the linear basal staining of p53 in normal laryngeal epithelium and noted its importance as a clue for early cancer development. Similar studies have determined the value of high p53 reactivity to identify pre-malignancy and malignancy in head and neck lesions. 10, 11 Although a possible relationship between p53 reactivity and malignant transformation has been reported in previous studies, the value of p53 reactivity in determination of prognosis and response to therapy is still not clearly understood. 1, 2, 6, 12 Some authors have found no significant relationship between p53 overexpression and tumour grade, localization or clinical stage, 12, 13 while others have found a correlation with tumour localization. 10 In our study, pathological stage and histological grade were not found to be significantly different in p53 immunoexpression, and nor was tumour localization.
The bcl-2 oncogene inhibits the apoptotic effect of certain hormones and cytokines, thereby extending the life of the cell. 14 Although the overexpression of bcl-2 protein is seen in follicular-centre cells of lymph nodes and certain other neoplastic cells, such as those from prostatic adenocarcinoma, squamous cell carcinoma lung cancer or nasopharyngeal carcinomas, the pathogenetic basis for the abnormality has not been clarified. 15 It has been suggested that, by extending cell life, bcl-2 overexpression makes cells more susceptible to genetic injury, thereby increasing the risk of malignant lesions. 13 Overexpression of the bcl-2 protein blocks the spontaneous apoptosis path -a critical factor in volumetric tumour doubling time -resulting in rapid accumulation of tumour cells.
A limited number of studies have found bcl-2 overexpression to be related to poor clinical outcome, while others denote its insignificance in the prognosis of laryngeal carcinomas. 1,2,4 -6 Other investigators have found bcl-2 overexpression to be a highly significant predictor for shorter disease-free interval and lower overall survival in early stages of head and neck squamous cell carcinoma. 16 In our study, bcl-2 expression was not significantly correlated with post-operative survival, tumour localization, pathological stage or histological tumour grade. p53 and bcl-2 are tumour regulatory proteins and their clinical importance has been shown in many malignant neoplasms. Since conventional semi-quantitative methods to evaluate these markers are subjective, interobserver and intraobserver results may not correlate well. Evaluation of immunoexpression with objective methods is expected to be more accurate, reliable and reproducible. Recent studies support the objectivity of quantitative immunoexpression using image-analysis systems. 17 In the present study, we used two different methods to evaluate p53 and bcl-2 immunoexpression: quantification using the SAMBA image analysis system and conventional S Yildirim, H Cermik, T Işitmangil et al. p53 and bcl-2 in laryngeal squamous cell carcinoma semi-quantification using histoscoring. We found that the two methods correlated well. Similar methods have been used to evaluate immunoexpression in a previous study. 17 In our study, p53 and bcl-2 reactivity had no significant prognostic power for postoperative survival in laryngeal squamous cell carcinoma.
